Department of Medicine Johns Hopkins School of Medicine Baltimore MD USA.
Department of Biostatistics Johns Hopkins Bloomberg School of Public Health Baltimore MD USA.
J Am Heart Assoc. 2024 Oct;13(19):e035797. doi: 10.1161/JAHA.124.035797. Epub 2024 Sep 30.
Prior analyses of the relationship between insurance status and receipt of tests and procedures have yielded conflicting findings and have focused on outpatient care. We sought to characterize the relationship between primary payer and diagnostic and procedural intensity, comparing rates of cardiac tests and procedures in matched hospitalized Medicaid and commercially insured patients.
We created a propensity score-matched sample of Medicaid and commercially insured adults hospitalized at all acute care hospitals in Kentucky, Maryland, New Jersey, and North Carolina from 2016 to 2018. The main outcome was receipt of a cardiac test or procedure: echocardiogram, stress test, cardiac catheterization (elective, in acute coronary syndrome, in ST-segment-elevation myocardial infarction), and pacemaker and subcutaneous cardiac rhythm monitor implantation. Generalized linear models with a hospital-specific indicator variable were estimated to calculate the adjusted odds of a commercially insured patient receiving a given test or procedure relative to a Medicaid patient. Models controlled for race, ethnicity, and zip code income quartile. Commercially insured patients were more likely to receive each cardiac test or procedure, with adjusted odds ratios ranging from 1.16 (95% CI, 1.00-1.34) for cardiac catheterization in ST-segment-elevation myocardial infarction to 1.40 (95% CI, 1.27-1.54) for pacemaker implantation.
Hospitalized commercially insured patients were more likely to undergo a range of cardiac tests and procedures, some of which may represent low-value care. This may be driven by a combination of physician and patient preference, financial incentives, and social determinants of health. Our findings support the need for hospital payment models focused on increasing value and reducing inequities.
先前对保险状况与接受检查和治疗之间关系的分析得出了相互矛盾的结果,并且集中在门诊护理上。我们试图描述主要付款人与诊断和治疗强度之间的关系,比较匹配的住院医疗补助和商业保险患者的心脏检查和治疗的比率。
我们创建了一个倾向评分匹配的样本,包括 2016 年至 2018 年肯塔基州、马里兰州、新泽西州和北卡罗来纳州所有急性护理医院住院的医疗补助和商业保险成年人。主要结果是接受心脏检查或治疗:超声心动图、压力测试、心脏导管插入术(选择性、急性冠状动脉综合征、ST 段抬高型心肌梗死)以及起搏器和皮下心脏节律监测器植入。使用带有医院特定指示变量的广义线性模型来计算商业保险患者接受特定检查或治疗的调整后几率,相对于医疗补助患者。模型控制了种族、族裔和邮政编码收入四分位数。商业保险患者更有可能接受每种心脏检查或治疗,调整后的优势比范围从 ST 段抬高型心肌梗死中心脏导管插入术的 1.16(95%CI,1.00-1.34)到起搏器植入的 1.40(95%CI,1.27-1.54)。
住院商业保险患者更有可能接受一系列心脏检查和治疗,其中一些可能代表低价值的护理。这可能是由医生和患者偏好、经济激励和健康的社会决定因素共同驱动的。我们的研究结果支持需要关注增加价值和减少不平等的医院支付模式。